Carregant...
Antiangiogenic Therapy for Diabetic Nephropathy
Angiogenesis has been shown to be a potential therapeutic target for early stages of diabetic nephropathy in a number of animal experiments. Vascular endothelial growth factor (VEGF) is the main mediator for abnormal angiogenesis in diabetic glomeruli. Although beneficial effects of anti-VEGF antibo...
Guardat en:
| Publicat a: | Biomed Res Int |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Hindawi
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5556994/ https://ncbi.nlm.nih.gov/pubmed/28835895 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2017/5724069 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|